Clinical Trial Update: Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction chemotherapy with gemcitabine and cisplatin followed by concurrent chemoradiation for unresectable pancreatic carcinoma has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Pancreatic Carcinoma Non-resectable | Phase 2 | Status: COMPLETED